By performing whole genome sequencing on PAH patients with a family history of the disease, these authors revealed deficits in TNIP2 and TRAF2, which encode proteins that regulate the activity of NF-κB, previously associated with inflammation and vascular remodelling in PAH. This evidence concerns the gene NFKB1 and pulmonary arterial hypertension.